We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Embolization Treatment for Uterine Fibroids

By HospiMedica staff writers
Posted on 30 Jul 2003
Symptomatic fibroid tumors can be treated with uterine fibroid embolization (UFE), a minimally invasive procedure that may reduce the number of uterine surgeries.

UFE can be used as an alternative to both hysterectomy and myomectomy. More...
An interventional radiologist injects small, specially engineered particles into the uterine arteries that supply blood to the fibroid. Once the particles stop the flow of blood to the fibroid, the tumor shrinks and symptoms are relieved. Usually, the fibroid shrinks to half its original size within the first three months following UFE. Because embolization is a permanent treatment, it is unusual for tumor regrowth to occur.

"Between 85-90% of UFE patients report reduced or completely alleviated symptoms and are happy with the procedure and its results,” noted Dr. Robert Vogelzang, professor and chief of vascular and interventional radiology at Northwestern University Medical School (Chicago, IL, USA; www.nums.nwu.edu). Dr. Vogelzang spoke about the procedure during a media briefing by the Radiological Society of North America (RSNA) in New York (NY, USA).

Patients with excessively large fibroids, fibroids outside the uterus, or active infections are not good UFE candidates. Long-term studies are needed to determine if UFE is uniformly safe for women who wish to become pregnant. A multicenter study indicated that successful pregnancies can occur after UFE.




Related Links:
Northwestern

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.